CISA’s CSAT Tool Hacked: Systems Offline, Free Webinarsby Lilu Anderson 25.06.2024CISA's CSAT Tool hacked; critical information at risk. Reset passwords, strengthen security, and stay updated through CISA's webinars.
SA Couple Faces Financial Woes After Good News Burgers Investmentby Mark Eisenberg 25.06.2024San Antonio couple fights to recover $25K investment in local restaurant amid lawsuits and no contact with the former owner. ...
LockBit Claims Massive Breach of Federal Reserve: 33TB Databy Lilu Anderson 25.06.2024"LockBit claims a massive 33TB data breach of the U.S. Federal Reserve, casting doubts as cybersecurity experts question the credibility ...
Enerpac Slides 9% on Q3 Revenue Miss – Strong Balance Sheetby Mark Eisenberg 25.06.2024Enerpac shares dropped 9% after a Q3 revenue miss despite EPS meeting expectations and improvements in gross margin and EBITDA.
David Kain on CDK Global: Cyberattack Lessons for Dealershipsby Lilu Anderson 25.06.2024David Kain on CDK Cyberattack: Learn from the recent attack's key insights on fortified cybersecurity and robust contingency planning for ...
O’Melveny Bolsters Team with Katten Finance Trio in CAby Mark Eisenberg 25.06.2024O'Melveny & Myers strengthens its California practice by hiring three finance experts from Katten, enhancing expertise in private credit transactions.
HireQuest CEO Buys $12.9K in Stock Amid Market Strugglesby Mark Eisenberg 25.06.2024HireQuest CEO buys $12.9K in shares, signaling strong confidence in company’s future amidst tough market and positive Q1 financials.
Old School vs. New Craze: Crypto Staking for High Yieldsby John Darbie 25.06.2024Explore high-yield crypto staking vs. the restaking trend. Dive into pros, risks, and top staking coins for long-term gains.
MetalCore Launches Ethereum Token Ahead of Latest Betaby John Darbie 25.06.2024Studio369 launches Ethereum token with MetalCore's Closed Beta 3, introducing new gameplay modes, economic features, and NFT in-game assets.
CTT Pharma CEO Buys $70 in Stock, Owns 5M+ Sharesby Mark Eisenberg 25.06.2024CTT Pharmaceutical CEO buys $70 in stock, signaling confidence. Despite recent gains, profitability concerns remain. Investors should monitor closely.